WisdomTree S&P 500 VIX Short-Term Futures 2.25x Daily Leveraged

This Exchange Traded Product (ETP) offers investors magnified exposure to S&P 500 VIX futures contracts. It is structured as a fully collateralized, UCITS-compliant investment vehicle. Its total return aims to deliver 2.25 times the daily movements of the S&P 500 VIX Short-Term Futures (0930-1600 ET) (USD) ER Index (VXXIDSPE). This return also incorporates earned interest revenue, with overall performance adjusted to account for product-related fees and expenses. Specifically, it targets a daily return that is 2.25 times the percentage change of the underlying index. For instance, a 1% increase in the S&P 500 VIX Short-Term Futures (0930-1600 ET) (USD) ER Index would generally lead to a 2.25% gain for the ETP, while a 1% decline in the index would result in a 2.25% loss for the ETP, prior to any charges.

WisdomTree S&P 500 VIX Short-Term Futures 2.25x Daily Leveraged trades as VILX.L on LSE. The company is classified in Financial Services / Asset Management - Leveraged and reports in GBP.

The current profile places the business in Asset Management - Leveraged. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Detailed operating-segment data is not available for this symbol yet.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

WisdomTree S&P 500 VIX Short-Term Futures 2.25x Daily Leveraged can be compared against peers such as Cavendish Financial plc, CEIBA Investments Limited, EPE Special Opportunities Limited, Ondo InsurTech Plc, Onward Opportunities Ltd, RM Infrastructure Income PLC.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of £12.15M, beta of -4.46, and return on equity of N/A.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

VILX.L currently shows total debt of N/A and beta of -4.46. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://www.wisdomtree.eu/etps/equities/boost-sp-500-vix-short-term-futures-225x-leverage-daily-etp

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.